Inve US ▾
AFAFCG

Advanced Flower Capital (AFCG) Q2 FY26 earnings call: the analyst Q&A

Earnings call· Jun 2026 (Q2 FY26)· Financials· Aug 13, 2026

Source: earnings call transcript

Executive summary

Advanced Flower Capital Inc. Q2 FY26 — Strong Liquidity and Strategic Redeployment into Lower Middle Market

Advanced Flower Capital navigated a challenging private credit environment in Q2 FY26 by focusing on strategic capital deployment into the lower middle market, which it views as offering compelling risk-adjusted returns. The company demonstrated strong financial health with increased NAV per share, significant share repurchases, and robust liquidity, while actively managing its legacy non-accrual cannabis portfolio through liquidation and foreclosure processes. Management emphasized a disciplined underwriting approach and the ability to leverage co-investment opportunities for larger deals, positioning AFC for continued growth despite market lumpiness.

Highlights

5
  • Net asset value per share increased by $0.35 to $8.25, driven by NII and share repurchases.

  • Repurchased approximately 839,000 shares for $2.8 million, which was $0.17 accretive to net asset value per share.

  • Ended the quarter with $106.5 million in cash and cash equivalents, providing substantial liquidity.

  • Net debt-to-equity improved to 1.0x from 1.09x QoQ, with an asset coverage ratio of 190% (vs. 150% requirement).

  • Deployed $102.0 million in new lower middle market commitments year-to-date FY26.

Concerns

4
  • Total investment income declined to $8.7 million from $9.8 million in Q1, primarily due to non-recurring exit fees in Q1.

  • Net investment income was $0.15 per share, providing 3x coverage of the $0.05 distribution, but lower than prior periods (implied by NII decline).

  • Legacy cannabis loans (Debi, DMA, Justice Grown) remain in non-accrual status, with ongoing liquidation/foreclosure processes.

  • Private credit ecosystem experiencing stress, with Fitch reporting a 6% default rate as of July 2026.

Deals & partnerships

Outpatient behavioral health platform Senior secured credit facility for refinancing existing debt and supporting future growth through acquisitions. $7.0M committed, $3.1M funded at close

Leading outpatient behavioral health platform in the Northeast with 10 locations. AFC's participation in a $25.0 million facility. Consistent with expanded lower middle market mandate.

Risks & headwinds

Stress in the private credit ecosystem Current (July 2026)

Fitch reporting a 6% default rate as of July 2026; Proskauer's Private Credit Default Index tracking similar upward trend.

Mitigation:Pullback in available capital creating compelling risk-adjusted return opportunities in the lower middle market; AFC's focus on sponsor relationships, internal sourcing, quick execution, and comprehensive maintenance covenant packages.

Legacy cannabis loans in non-accrual Ongoing

Debi, DMA, Justice Grown loans.

Mitigation:Active liquidation process for Debi (binding term sheet for $12.5M sale) and DMA (two dispensaries sold); Article 9 foreclosures commenced for Justice Grown assets.

Lack of equity capital in the cannabis industry Ongoing

Not quantified, but described as "still difficult environment to raise equity capital."

Mitigation:AFC's cautious approach to cannabis lending and focus on redeploying capital into other lower middle market opportunities.

Lumpiness in originations Near term

Q1 originations were $80.0 million, Q2 was less.

Mitigation:Active $1.3 billion pipeline; ability to leverage co-investment relief order with SEC to participate with affiliates for larger opportunities; syndication of deals above target hold threshold.

What to watch in Q3 FY26

Debi asset sale completion

This year (FY26)
Current Binding term sheet signed for $12.5M sale, $2.0M non-refundable deposit received.
Target Transaction close and receipt of proceeds.

Why it matters

Resolution of a significant non-accrual legacy asset and inflow of capital.

Regarding [ Debi ], the receiver has continued the liquidation process. During the quarter, [ Debi ] entered into a binding term sheet to sell two additional assets of [ Debi ] for $12.5 million in cash proceeds. Subsequent to quarter end, [ Debi ] earned a $2.0 million non-refundable deposit on the purchase, and we expect the transaction to close this year.

Find out whether AFCG delivers this. Inve re-checks your case every morning.

Q&A highlights

Asked about the perceived slowdown in new borrower funding in Q2 compared to Q1, despite the active pipeline, and how to think about execution going forward.

Daniel Neville acknowledged lumpiness in originations, noting $80.0 million in Q1 vs. less in Q2, but emphasized the quality and pricing of the $1.3 billion pipeline. He stated they are advancing opportunities and expect continued momentum, albeit with episodic deal flow.

“originations are going to be lumpy. You saw in Q1 we did about $80.0 million. We did less in Q2. And so I think that we are advancing a bunch of opportunities through the pipeline and are seeing good looks and we'll look to continue the momentum over the course of the year, but it will be lumpy and episodic just given the deals that we're hunting.”

asked by Aaron Grey · answered by Daniel Neville

2 min read 5 chapters

Detailed narrative

Private Credit Market Dynamics

The private credit ecosystem is experiencing stress, with default rates rising (Fitch reported 6% as of July 2026). This has led to a pullback in available capital, particularly in the lower middle market, which AFC views as creating a compelling vintage for new originations due to rational competition and strong risk-adjusted returns. Unlike the upper middle market, the lower middle market rewards lenders with sponsor relationships, internal sourcing, and quick execution, aligning with AFC's strategy.

Portfolio Evolution and Strategy

AFC's investment portfolio fair value grew to $289.8 million across 17 companies, up from $279.2 million across 15 companies in the prior quarter. The entire portfolio consists of senior secured first lien debt investments, with a weighted average yield of 13.2% (excluding non-accrual loans). The company is actively redeploying capital into cash-flowing borrowers with $5.0 million to $50.0 million EBITDA, primarily in sponsored transactions, maintaining a disciplined underwriting approach with strong structural protections.

Legacy Cannabis Portfolio Resolution

Efforts continue to resolve non-accrual legacy cannabis loans. For Debi, a binding term sheet was signed to sell two assets for $12.5 million, with a $2.0 million non-refundable deposit received, and the transaction is expected to close this year. For DMA, two of three dispensaries were sold subsequent to quarter end. Justice Grown is in maturity default, with Article 9 foreclosures commenced on vertically integrated assets in New Jersey and three operating dispensaries in Pennsylvania, with a robust marketing process underway.

Liquidity and Capital Allocation

AFC ended the quarter with $106.5 million in cash and cash equivalents, providing substantial liquidity for new investments and other capital allocation opportunities. The company repurchased 839,000 shares for $2.8 million at an average price of $3.29 per share, which was $0.17 accretive to NAV per share. Approximately $2.2 million remains available under the $5.0 million share repurchase program. Net debt-to-equity improved to 1.0x from 1.09x, and the asset coverage ratio stood at 190% against a 150% requirement.

Origination Pipeline and Future Opportunities

The investment pipeline remains active with $1.3 billion across diverse industries, focusing on lower middle market opportunities. Management acknowledged that originations can be lumpy, with Q1 funding $80.0 million and Q2 being less, but expressed confidence in the quality and pricing of opportunities. AFC can leverage its co-investment relief order with the SEC to participate in larger opportunities alongside affiliates and syndicate deals above its target hold threshold, ensuring flexibility in capital deployment.

Summary of the company's earnings call; see how call summaries are prepared. Not investment advice.